Abstract
Paraneoplastic movement disorders are rare, autoimmune-mediated, nonmetastatic complications of malignant neoplasms. Common paraneoplastic movement disorders include paraneoplastic chorea, dystonia, cerebellar degeneration, different types of encephalitis, opsoclonus-myoclonus syndrome, stiff person syndrome, and neuromyotonia. Syndromes usually develop before tumor diagnosis, have subacute onset, and are associated with serum or cerebrospinal fluid antibodies. Two types of antibodies can be distinguished: antibodies against nuclear and cytoplasmic neuronal antigens (anti-Hu, anti-Ri, anti-Yo, anti-Ma, anti-CV2/CRMP5, anti-Gephrin, and anti-GABATRAP) and antibodies recently identified against cell surface and synaptic proteins (anti-NMDAR, anti-LGI1, and anti-Caspr2). These two types differ from each other in a few important aspects. Antibodies against cell surface and synaptic protein disrupt cell-surface antigens. Clinical symptoms are related to the disruption of antigens and potentially can be reversed by immunotherapy. The association between these antibodies and malignancy is much less consistent. On the other hand, antibodies against nuclear and cytoplasmic neuronal antigens seem to be not pathogenic; however, they most likely indicate a T-cell-mediated immune response against neurons. Due to T-cell-mediated neuronal loss, response to immunotherapy is generally disappointing. Early recognition of all these diseases is crucial because it may lead to the disclosure of occult cancer. This review is focused on paraneoplastic movement disorders with emphasis on clinical presentations, investigational findings, and therapeutic results.
References
Ameli, R., Snow, J., Rakocevic, G., and Dalakas M.C. (2005). A neuropsychological assessment of phobias in patients with stiff person syndrome. Neurology 64, 1961–1963.10.1212/01.WNL.0000163984.71993.FESearch in Google Scholar PubMed
Anagnostou, E. and Zambelis, T. (2012). Botulinum toxin A in anti-GAD positive stiff limb syndrome. Muscle Nerve 46, 457–458.10.1002/mus.23416Search in Google Scholar PubMed
Antoine, J.C., Absi, L., Honnorat, J., Boulesteix, J.M., de Brouker, T., Vial, C., Butler, M., De Camilli, P., and Michel, D. (1999). Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch. Neurol. 56, 172–177.10.1001/archneur.56.2.172Search in Google Scholar PubMed
Armstrong, M.B., Robertson, P.L., and Castle V.P. (2005). Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis. Pediatr. Neurol. 33, 365–367.10.1016/j.pediatrneurol.2005.05.018Search in Google Scholar PubMed
Baets, J., Pals, P., Bergmans, B., Foncke, E., Smets, K., Hauman, H., Vanderwegen, L., and Cras, P. (2006). Opsoclonus-myoclonus syndrome: a clinicopathological confrontation. Acta Neurol. Belg. 106, 142–146.Search in Google Scholar
Barker, R.A., Revesz, T., Thom, M., Marsden, C.D., and Brown, P. (1998). Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J. Neurol. Neurosurg. Psychiatry 65, 633–640.10.1136/jnnp.65.5.633Search in Google Scholar PubMed PubMed Central
Bataller, L., Graus, F., Saiz, A., and Vilchez, J.J. (2001). Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124, 437–443.10.1093/brain/124.2.437Search in Google Scholar PubMed
Bataller, L., Kleopa, K.A., Wu, G.F., Rossi, J.E., Rosenfeld, M.R, and Dalmau, J. (2007). Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J. Neurol. Neurosurg. Psychiatry 78, 381–385.10.1136/jnnp.2006.100644Search in Google Scholar PubMed PubMed Central
Bayreuther, C., Bourg, V., Dellamonica, J., Borg, M., Bernardin, G., and Thomas, P. (2009). Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord. 11, 261–265.10.1684/epd.2009.0266Search in Google Scholar PubMed
Beck, S., Fuehlhuber, V., Krasenbrink, I., Tschernatsch, M., Kneifel, N., Kirsten, A., Jaeger, C., Kaps, M., Preissner, K.T., Lang, B., et al. (2007). IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome. J. Neuroimmunol. 185, 145–149.10.1016/j.jneuroim.2007.01.006Search in Google Scholar PubMed
Blaes, F., Fuehlhuber, V., Korfei, M., Tschernatsch, M., Behnisch, W., Rostasy, K., Hero, B., Kaps, M., and Preissner, K.T. (2005). Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann. Neurol. 58, 313–317.10.1002/ana.20539Search in Google Scholar PubMed
Boronat, A., Sabater, L., Saiz, A., Dalmau, J., and Graus, F. (2011). GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76, 795–800.10.1212/WNL.0b013e31820e7b8dSearch in Google Scholar
Brashear, H.R. and Phillips, L.H. 2nd. (1991). Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 41, 1588–1592.10.1212/WNL.41.10.1588Search in Google Scholar
Brown, P. and Marsden, C.D. (1999). The stiff man and stiff man plus syndromes. J. Neurol. 246, 648–652.10.1007/s004150050425Search in Google Scholar
Brunklaus, A., Pohl, K., Zuberi, S.M., and de Sousa, C. (2011). Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics 128, 388–394.10.1542/peds.2010-3114Search in Google Scholar
Butler, M.H., Hayashi, A., Ohkoshi, N., Villmann, C., Becker, C.M., Feng, G., De Camilli, P., and Solimena, M. (2000). Autoimmunity to gephyrin in stiff-man syndrome. Neuron. 26, 307–312.10.1016/S0896-6273(00)81165-4Search in Google Scholar
Caviness, J., Forsyth, P., Layton, D., and McPhee, T.J. (1995). The movement disorder of adult opsoclonus. Mov. Disord. 10, 22–27.10.1002/mds.870100106Search in Google Scholar PubMed
Dalakas, M.C., Fujii, M., Li, M., and McElroy, B. (2000). The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55, 1531–1535.10.1212/WNL.55.10.1531Search in Google Scholar PubMed
Dalakas, M.C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., and McElroy, B. (2001). High-dose intravenous immune globulin for stiff-person syndrome. N. Engl. J. Med. 345, 1870–1876.10.1056/NEJMoa01167Search in Google Scholar PubMed
Dalmau, J., Graus, F., Villarejo, A., Posner, J.B., Blumenthal, D., Thiessen, B., Saiz, A., Meneses, P., and Rosenfeld, M.R. (2004). Clinical analysis of anti-Ma2-associated encephalitis. Brain 127, 1831–1844.10.1093/brain/awh203Search in Google Scholar PubMed
Dalmau, J., Tüzün, E., Wu, H.Y., Masjuan, J., Rossi, J.E., Voloschin, A., Baehring, J.M., Shimazaki, H., Koide, R., King, D., et al. (2007). Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 61, 25–36.10.1002/ana.21050Search in Google Scholar PubMed PubMed Central
Dalmau, J., Gleichman, A.J., Hughes, E.G., Rossi, J.E., Peng, X., Lai, M., Dessain, S.K., Rosenfeld, M.R., Balice-Gordon, R., and Lynch, D.R. (2008). Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 7, 1091–1098.10.1016/S1474-4422(08)70224-2Search in Google Scholar
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M.R., and Balice-Gordon, R. (2011). Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 10, 63–74.10.1016/S1474-4422(10)70253-2Search in Google Scholar
Darnell, R.B. and Posner, J.B. (2003). Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 349, 1543–1554.10.1056/NEJMra023009Search in Google Scholar PubMed
de Graaff, E., Maat, P., Hulsenboom, E., van den Berg, R., van den Bent, M., Demmers, J., Lugtenburg, P.J., Hoogenraad, C.C., and Sillevis Smitt, P. (2012). Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann. Neurol. 71, 815–824.10.1002/ana.23550Search in Google Scholar PubMed
De Grandis, E., Parodi, S., Conte, M., Angelini, P., Battaglia, F., Gandolfo, C., Pessagno, A., Pistoia, V., Mitchell, W.G., Pike, M., et al. (2009). Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics 40, 103–111.10.1055/s-0029-1237723Search in Google Scholar PubMed
De la Casa-Fages, B., Anaya, F., Gabriel-Ortemberg, M., and Grandas, F. (2013). Treatment of stiff-person syndrome with chronic plasmapheresis. Mov. Disord. 28, 396–397.10.1002/mds.25167Search in Google Scholar PubMed
Derksen, A., Stettner, M., Stöcker, W., and Seitz R.J. (2013). Antiglycine receptor-related stiff limb syndrome in a patient with chronic lymphocytic leukaemia. Br. Med. J. Case Rep. 20, 2013.10.1136/bcr-2013-008667Search in Google Scholar PubMed PubMed Central
Dorresteijn, L.D., Kappelle, A.C., Renier, W.O., and Gijtenbeek, J.M. (2002). Antiamphiphysin associated limbic encephalitis: a paraneoplastic presentation of small-cell lung carcinoma. J. Neurol. 249, 1307–1308.10.1007/s00415-002-0677-5Search in Google Scholar PubMed
Geis, C., Beck, M., Jablonka, S., Weishaupt, A., Toyka, K.V., Sendtner, M., and Sommer, C. (2009). Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca2+]i rise in embryonic motoneurons. Neurobiol. Dis. 36, 191–199.10.1016/j.nbd.2009.07.011Search in Google Scholar PubMed
Geis, C., Weishaupt, A., Hallermann, S., Grünewald, B., Wessig, C., Wultsch, T., Reif, A., Byts, N., Beck, M., Jablonka, S., et al. (2010). Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 133, 3166–3180.10.1093/brain/awq253Search in Google Scholar PubMed
Geis, C., Grünewald, B., Weishaupt, A., Wultsch, T., Toyka, K.V., Reif, A., and Sommer, C. (2012). Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. J. Neural Transm. (Vienna) 119, 981–985.10.1007/s00702-012-0773-3Search in Google Scholar PubMed
Gordon, M.F., Pullman, S., and McDonald, T. (1991). Plasmapheresis in the treatment of stiff-man syndrome. Neurology 41, 223.Search in Google Scholar
Gorman, M.P. (2010). Update on diagnosis, treatment, and prognosis in opsoclonusmyoclonus-ataxia syndrome. Curr. Opin. Pediatr. 22, 745–750.10.1097/MOP.0b013e32833fde3fSearch in Google Scholar PubMed
Gozzard, P. and Maddison, P. (2010). Which antibody and which cancer in which paraneoplastic syndromes. Pract. Neurol. 10, 260–270.10.1136/jnnp.2010.224105Search in Google Scholar PubMed
Graus, F., Keime-Guibert, F., Rene, R., Benyahia, B., Ribalta, T., Ascaso, C., Escaramis, G., and Delattre, J.Y. (2001). Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124, 1138–1148.10.1093/brain/124.6.1138Search in Google Scholar PubMed
Graus, F., Saiz, A., Lai, M., Bruna, J., López, F., Sabater, L., Blanco, Y., Rey, M.J., Ribalta, T., and Dalmau, J. (2008). Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 71, 930–936.10.1212/01.wnl.0000325917.48466.55Search in Google Scholar PubMed PubMed Central
Greenlee, J.E., Clawson, S.A., Hill, K.E., Wood B., Clardy, S.L., Tsunoda, I., and Carlson, N.G. (2015). Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. PLoS One 10, e0123446.10.1371/journal.pone.0123446Search in Google Scholar PubMed PubMed Central
Gultekin, S.H., Rosenfeld, M.R., Voltz, R., Eichen, J., Posner, J.B., and Dalmau, J. (2000). Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123, 1481–1494.10.1093/brain/123.7.1481Search in Google Scholar PubMed
Hoffmann, L.A., Jarius, S., Pellkofer, H.L., Schueller, M., Krumbholz, M., Koenig, F., Johannis, W., la Fougere, C., Newman, T., Vincent, A., et al. (2008). Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J. Neurol. Neurosurg. Psychiatry 79, 767–773.10.1136/jnnp.2007.118588Search in Google Scholar PubMed
Honnorat, J., Cartalat-Carel, S., Ricard, D., Camdessanche, J.P., Carpentier, A.F., Rogemond, V., Chapuis, F., Aguera, M., Decullier, E., Duchemin, A.M., et al. (2009). Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J. Neurol. Neurosurg. Psychiatry 80, 412–416.10.1136/jnnp.2007.138016Search in Google Scholar PubMed PubMed Central
Honnorat, J., Trillet, M., Antoine, J.C., Aguera, M., Dalmau, J., and Graus, F. (1997). Paraneoplastic opsomyoclonus, cerebellar ataxia and encephalopathy associated with anti-Purkinje cell antibodies. J. Neurol. 244, 333–335.10.1007/s004150050097Search in Google Scholar PubMed
Hutchinson, M., Waters, P., McHugh, J., Gorman, G., O’Riordan, S., Connolly, S., Hager, H., Yu, P., Becker, C.M., and Vincent, A. (2008). Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71, 1291–1292.10.1212/01.wnl.0000327606.50322.f0Search in Google Scholar PubMed
Iizuka, T., Yoshii, S., Kan, S., Hamada, J., Dalmau, J., Sakai, F., and Mochizuki, H. (2010). Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J. Neurol. 257, 1686–1691.10.1007/s00415-010-5604-6Search in Google Scholar PubMed PubMed Central
Irani, S.R., Alexander, S., Waters, P., Kleopa, K.A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., and Vincent, A. (2010a). Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133, 2734–2748.10.1093/brain/awq213Search in Google Scholar PubMed PubMed Central
Irani, S.R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi M.S., Friese M.A., Galea, I., Kullmann, D.M., Beeson, D., et al. (2010b). N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain 133, 1655–1667.10.1093/brain/awq113Search in Google Scholar PubMed PubMed Central
Ishii, A., Hayashi, A., Ohkoshi, N., Matsuno, S., and Shoji, S. (2004). Progressive encephalomyelitis with rigidity associated with antiamphiphysin antibodies. J. Neurol. Neurosurg. Psychiatry 75, 661–662.Search in Google Scholar
Keime-Guibert, F., Graus, F., Fleury, A., René, R., Honnorat, J., Broet, P., and Delattre, J.Y. (2000). Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J. Neurol. Neurosurg. Psychiatry 68, 479–482.10.1136/jnnp.68.4.479Search in Google Scholar PubMed PubMed Central
Kinirons, P., Fulton, A., Keoghan, M., Brennan, P., Farrell, M.A., and Moroney, J.T. (2003). Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody. Neurology 61, 1623–1624.10.1212/01.WNL.0000095958.33713.57Search in Google Scholar PubMed
Klaas, J.P., Ahlskog, E., Pittock, S.J., Matsumoto, J.Y., Aksamit, A.J., Bartleson, J.D., Kumar, R., McEvoy, K.F., and McKeon, A. (2012). Adult-onset opsoclonus-myoclonus syndrome. Arch. Neurol. 69, 1598–1607.10.1001/archneurol.2012.1173Search in Google Scholar PubMed
Kleinig, T.J., Thompson, P.D., Matar, W., Duggins, A., Kimber, T.E., Morris, J.G., Kneebone, C.S., and Blumbergs, P.C. (2008). The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov. Disord. 23, 1256–1261.10.1002/mds.22073Search in Google Scholar PubMed
Kyskan, R., Chapman, K., Mattman, A., and Sin, D. (2013). Antiglycine receptor antibody and encephalomyelitis with rigidity and myoclonus (PERM) related to small cell lung cancer. Br. Med. J. Case Rep. 21, 2013.10.1136/bcr-2013-010027Search in Google Scholar PubMed PubMed Central
Lai, M., Hughes, E.G., Peng, X., Zhou, L., Gleichman, A.J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M.D., et al. (2009). AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann. Neurol. 65, 424–434.10.1002/ana.21589Search in Google Scholar PubMed PubMed Central
Lai, M., Huijbers, M.G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J.K., and Dalmau, J. (2010). Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 9, 776–785.10.1016/S1474-4422(10)70137-XSearch in Google Scholar
Lancaster, E. and Dalmau, J. (2012). Neuronal autoantigens – pathogenesis, associated disorders and antibody testing. Nat. Rev. Neurol. 8, 380–390.10.1038/nrneurol.2012.99Search in Google Scholar
Lancaster, E., Huijbers, M.G., Bar, V., Boronat, A., Wong, A., Martinez-Hernandez, E., Wilson, C., Jacobs, D., Lai, M., Walker, R.W., et al. (2011). Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol. 69, 303–311.10.1002/ana.22297Search in Google Scholar
Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M.B., Grisold, W., Kimura, A., et al. (2010). Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 9, 67–76.10.1016/S1474-4422(09)70324-2Search in Google Scholar
Lancaster, E., Martinez-Hernandez, E., Titulaer, M.J., Boulos, M., Weaver, S., Antoine, J.C., Liebers, E., Kornblum, C., Bien, C.G., Honnorat, J., et al. (2011). Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77, 1698–1701.10.1212/WNL.0b013e3182364a44Search in Google Scholar
Lorish, T.R., Thorsteinsson, G., and Howard, F.M. (1989). Stiff-man syndrome updated. Mayo Clin. Proc. 64, 629–636.10.1016/S0025-6196(12)65339-7Search in Google Scholar
Luque, F.A., Furneaux, H.M., Ferziger, R., Rosenblum, M.K., Wray, S.H., Schold, S.C. Jr, Glantz, M.J., Jaeckle, K.A., Biran, H., and Lesser, M. (1991). Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 29, 241–251.10.1002/ana.410290303Search in Google Scholar PubMed
Manto, M.U., Laute, M.A., Aguera, M., Rogemond, V., Pandolfo, M., and Honnorat, J. (2007). Effects of antiglutamic acid decarboxylase antibodies associated with neurological diseases. Ann. Neurol. 61, 544–551.10.1002/ana.21123Search in Google Scholar PubMed
Mas, N., Saiz, A., Leite M.I., Waters, P., Baron, M., Castaño, D., Sabater, L., Vincent, A., and Graus F. (2011). Antiglycine-receptor encephalomyelitis with rigidity. J. Neurol. Neurosurg. Psychiatry 82, 1399–1401.10.1136/jnnp.2010.229104Search in Google Scholar PubMed
Mathew, R.M., Vandenberghe, R., Garcia-Merino, A., Yamamoto, T., Landolfi, J.C., Rosenfeld, M.R., Rossi, J.E., Thiessen, B., Dropcho, E.J., and Dalmau, J. (2007). Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68, 900–905.10.1212/01.wnl.0000252379.81933.80Search in Google Scholar PubMed PubMed Central
Matsumoto, L., Yamamoto, T., Higashihara, M., Sugimoto, I., Kowa, H., Shibahara, J., Nakamura, K., Shimizu, J., Ugawa, Y., Goto, J., et al. (2007). Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes. Mov. Disord. 22, 728–731.10.1002/mds.21314Search in Google Scholar PubMed PubMed Central
Meinck, H.M. (2001). Stiff man syndrome. CNS Drugs 15, 515–526.10.1007/978-3-642-87602-8_86Search in Google Scholar
Meinck, H.M. and Thompson, P.D. (2002). Stiff man syndrome and related conditions. Mov. Disord. 17, 853–866.10.1002/mds.10279Search in Google Scholar PubMed
Mitchell, W.G. and Snodgrass, S.R. (1990). Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome. J. Child Neurol. 5, 153–158.10.1177/088307389000500217Search in Google Scholar PubMed
Mitchell, W.G., Brumm, V.L., Azen, C.G., Patterson, K.E., Aller, S.K., and Rodriguez, J. (2005). Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia. Pediatrics 116, 901–907.10.1542/peds.2004-2377Search in Google Scholar PubMed
Morales La Madrid, A., Rubin, C.M., Kohrman, M., Pytel, P., and Cohn, S.L. (2012). Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma. Pediatr. Blood Cancer 58, 472–474.10.1002/pbc.23131Search in Google Scholar PubMed
Murinson, B.B. and Guarnaccia, J.B. (2008). Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 71, 1955–1958.10.1212/01.wnl.0000327342.58936.e0Search in Google Scholar PubMed PubMed Central
Nakamagoe, K., Ohkoshi, N., Hayashi, A., Hisahara, S., and Shoji, S. (1995). Marked clinical improvement by plasmapheresis in a patient with stiff-man syndrome: a case with a negative anti-GAD antibody. Rinsho Shinkeigaku 35, 897–900.Search in Google Scholar
Nakane, S., Fujita, K., Shibuta, Y., Matsui, N., Harada, M., Urushihara, R., Nishida, Y., Izumi, Y., and Kaji, R. (2013). Successful treatment of stiff person syndrome with sequential use of tacrolimus. J. Neurol. Neurosurg. Psychiatry 84, 1177–1180.10.1136/jnnp-2013-305425Search in Google Scholar PubMed
O’Toole, O., Lennon, V.A., Ahlskog, J.E., Matsumoto, J.Y., Pittock, S.J., Bower, J., Fealey, R., Lachance, D.H., and McKeon, A. (2013). Autoimmune chorea in adults. Neurology 80, 1133–1144.10.1212/WNL.0b013e3182886991Search in Google Scholar PubMed PubMed Central
Orange, D., Frank, M., Tian, S., Dousmanis, A., Marmur, R., Buckley, N., Parveen, S., Graber, J.J., Blachère, N., and Darnell RB. (2012). Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens. Arch. Neurol. 9, 1132–1140.10.1001/archneurol.2012.595Search in Google Scholar PubMed PubMed Central
Pittock, S.J., Lucchinetti, C.F., Parisi, J.E., Benarroch, E.E., Mokri, B., Stephan, C.L., Kim, K.K., Kilimann, M.W., and Lennon, V.A. (2005). Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann. Neurol. 58, 96–107.10.1002/ana.20529Search in Google Scholar PubMed
Pittock, S.J., Parisi, J.E., McKeon, A., Roemer, S.F., Lucchinetti, C.F., Tan, K.M., Keegan, B.M., Hunter, S.F., Duncan, P.R., Baehring, J.M., et al. (2010) Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch. Neurol. 67, 1109–1115.10.1001/archneurol.2010.209Search in Google Scholar PubMed
Posner, J.B. and Davines, F.A. (1995). Paraneoplastic syndromes. Neurol. Complications Cancer, 353–385.Search in Google Scholar
Pranzatelli, M.R. (1996). The immunopharmacology of the opsoclonus myoclonus syndrome. Clin. Neuropharmacol. 19, 1–47.10.1097/00002826-199619010-00001Search in Google Scholar PubMed
Pranzatelli, M.R., Tate, E.D., Swan, J.A., Travelstead, A.L., Colliver, J.A., Verhulst, S.J., Crosley, C.J., Graf, W.D., Joseph, S.A., Kelfer, H.M., et al. (2010). B cell depletion therapy for new onset opsoclonus-myoclonus. Mov. Disord. 25, 238–242.10.1002/mds.22941Search in Google Scholar PubMed
Pranzatelli, M.R., Tate, E.D., Shenoy, S., and Travelstead, A.L. (2012). Ofatumumab for a rituximaballergic child with chronic-relapsing paraneoplastic opsoclonus myoclonus. Pediatr. Blood Cancer 58, 988–991.10.1002/pbc.23187Search in Google Scholar PubMed
Psimaras, D., Carpentier, A.F., and Rossi, C. (2010). Cerebrospinal fluid study in paraneoplastic syndromes. J. Neurol. Neurosurg. Psychiatry 81, 42–45.10.1136/jnnp.2008.159483Search in Google Scholar PubMed
Raju, R., Rakocevic, G., Chen, Z., Hoehn, G., Semino-Mora, C., Shi, W., Olsen, R., and Dalakas, M.C. (2006). Autoimmunity to GABAA receptor associated protein in stiff-person syndrome. Brain 129, 3270–3276.10.1093/brain/awl245Search in Google Scholar PubMed
Rakocevic, G., Raju, R., and Dalakas, M.C. (2004). Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch. Neurol. 61, 902–904.10.1001/archneur.61.6.902Search in Google Scholar PubMed
Rojas, I., Graus, F., Keime-Guibert, F., Reñé, R., Delattre, J.Y., Ramón, J.M., Dalmau, J., and Posner, J.B. (2000). Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55, 713–715.10.1212/WNL.55.5.713Search in Google Scholar PubMed
Rosenfeld, M.R., Eichen, J.G., Wade, D.F., Posner, J.B., and Dalmau, J. (2001). Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann. Neurol. 50, 339–348.10.1002/ana.1288Search in Google Scholar
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., and Graus, F. (2008). Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131, 2553–2563.10.1093/brain/awn183Search in Google Scholar
Scarff, J.R., Iftikhar, B., Tatugade, A., Choi, J., and Lippmann, S. (2011) Opsoclonus myoclonus. Innov. Clin. Neurosci. 8, 29–31.Search in Google Scholar
Shams’ili, S., Grefkens, J., de Leeuw, B., van den Bent, M., Hooijkaas, H., van der Holt, B., Vecht, C., and Sillevis Smitt, P. (2003). Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126, 1409–1418.10.1093/brain/awg133Search in Google Scholar
Shams’ili, S., de Beukelaar, J., Gratama, J.W., Hooijkaas, H. van den Bent, M., van ’t Veer, M., and Sillevis Smitt, P. (2006). An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J. Neurol. 253, 16–20.10.1007/s00415-005-0882-0Search in Google Scholar
Sillevis Smitt, P.A., Manley, G.T., and Posner, J.B. (1995). Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 45, 1873–1878.10.1212/WNL.45.10.1873Search in Google Scholar
Sillevis Smitt, P.A., Grefkens, J., de Leeuw, B., van den Bent, M., van Putten, W., Hooijkaas, H., Vecht, C. (2002). Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J. Neurol. 249, 745–753.10.1007/s00415-002-0706-4Search in Google Scholar
Sommer, C., Weishaupt, A., Brinkhoff, J., Biko, L., Wessig, C., Gold, R., and Toyka, K.V. (2005). Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 365, 1406–1411.10.1016/S0140-6736(05)66376-3Search in Google Scholar
Spay, A.J. and Chen, R. (2006). Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve 34, 677–690.10.1002/mus.20653Search in Google Scholar
Squintani, G., Bovi, T., Ferigo, L., Musso, A.M., Ottaviani, S., Moretto, G., Morgante, F., and Tinazzi, M. (2012). Efficacy of pregabalin in a case of stiff-person syndrome: clinical and neurophysiological evidence. J. Neurol. Sci. 15, 314.10.1016/j.jns.2011.10.023Search in Google Scholar
Stich, O., Jarius, S., Kleer B., Rasiah, C., Voltz, R., and Rauer, S. (2007). Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes. J. Neuroimmunol. 183, 220–224.10.1016/j.jneuroim.2006.11.008Search in Google Scholar
Tanaka, K., Tanaka, M., Igarashi, S., Onodera, O., Miyatake, T., and Tsuji, S. (1995). Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin. Neurol. Neurosurg. 97, 101–105.10.1016/0303-8467(95)00006-6Search in Google Scholar
Thompson, P.D. (1994). Stiff people. Movement Disorders 3. C.D. Marsden and S. Fahn, eds. (Oxford, UK: Butterworth-Heinemann), pp. 373–405.Search in Google Scholar
Titulaer, M.J., Soffietti, R., Dalmau, J., Gilhus, N.E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P.A., Tanasescu, R., et al. (2011). Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur. J. Neurol. 18, 19–27.10.1111/j.1468-1331.2010.03220.xSearch in Google Scholar PubMed PubMed Central
van Broekhoven, F., de Graaf, M.T., Bromberg, J.E., Hooijkaas, H., van den Bent, M.J., de Beukelaar, J.W., Khan, N.A., Gratama, J.W., van der Geest, J.N., Frens, M., et al. (2010). Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 81, 1341–1344.10.1136/jnnp.2009.177865Search in Google Scholar PubMed
Vasconcelos, O.M. and Dalakas, M.C. (2003). Stiff-person syndrome. Curr. Treat. Options Neurol. 5, 79–90.10.1007/s11940-003-0024-xSearch in Google Scholar PubMed
Vernino, S. and Lennon, V.A. (2004). Autoantibody profiles and neurological correlations of thymoma. Clin. Cancer Res. 10, 7270–7275.10.1158/1078-0432.CCR-04-0735Search in Google Scholar PubMed
Uchuya, M., Graus, F., Vega, F., and Rene, R. (1996). Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J. Neurol. Neurosurg. Psychiatry 60, 388–392.10.1136/jnnp.60.4.388Search in Google Scholar PubMed PubMed Central
Vigliani, M.C., Honnorat, J., Antoine, J.C., Vitaliani, R., Giometto, B., Psimaras, D., Franchino, F., Rossi, C., and Graus, F. (2011). Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience. J. Neurol. 258, 2058–2068.10.1007/s00415-011-6074-1Search in Google Scholar PubMed
Wilken, B., Baumann, M., Bien, C.G., Hero, B., Rostasy, K., and Hanefeld, F. (2008) Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses. Eur. J. Paediatr. Neurol. 12, 51–55.10.1016/j.ejpn.2007.05.005Search in Google Scholar PubMed
Wong, A. (2007). An update on opsoclonus. Curr. Opin. Neurol. 20, 25–31.10.1097/WCO.0b013e3280126b51Search in Google Scholar PubMed
©2018 Walter de Gruyter GmbH, Berlin/Boston
